{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:26:57Z","timestamp":1787023617962,"version":"build-2736575974"},"reference-count":34,"publisher":"Impact Journals, LLC","issue":"50","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,12,13]]},"DOI":"10.18632\/oncotarget.13074","type":"journal-article","created":{"date-parts":[[2016,11,4]],"date-time":"2016-11-04T07:43:25Z","timestamp":1478245405000},"page":"83148-83159","source":"Crossref","is-referenced-by-count":40,"title":["Malignant ascites enhances migratory and invasive properties of ovarian cancer cells with membrane bound IL-6R\n                    <i>in vitro<\/i>"],"prefix":"10.18632","volume":"7","author":[{"given":"Soochi","family":"Kim","sequence":"first","affiliation":[{"name":"Interdisciplinary Program in Cancer Biology, College of Medicine, Seoul National University, Seoul, Republic of Korea"},{"name":"Cancer Research Institute, Seoul National University, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HyeRan","family":"Gwak","sequence":"additional","affiliation":[{"name":"Cancer Research Institute, Seoul National University, Seoul, Republic of Korea"},{"name":"Biomodulation, Department of Agricultural Biotechnology, Seoul National University, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee Seung","family":"Kim","sequence":"additional","affiliation":[{"name":"Cancer Research Institute, Seoul National University, Seoul, Republic of Korea"},{"name":"Department of Obstetrics and Gynecology, Seoul National University, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boyun","family":"Kim","sequence":"additional","affiliation":[{"name":"Cancer Research Institute, Seoul National University, Seoul, Republic of Korea"},{"name":"Nano System Institute, Seoul National University, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danny N.","family":"Dhanasekaran","sequence":"additional","affiliation":[{"name":"Stephenson Cancer Center, University of Oklahoma Health Sciences Center, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong Sang","family":"Song","sequence":"additional","affiliation":[{"name":"Interdisciplinary Program in Cancer Biology, College of Medicine, Seoul National University, Seoul, Republic of Korea"},{"name":"Cancer Research Institute, Seoul National University, Seoul, Republic of Korea"},{"name":"Biomodulation, Department of Agricultural Biotechnology, Seoul National University, Seoul, Republic of Korea"},{"name":"Department of Obstetrics and Gynecology, Seoul National University, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,11,4]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nrclinonc.2015.224","article-title":"Can advanced-stage ovarian cancer be cured?","volume":"13","author":"Narod","year":"2016","journal-title":"Nat Rev Clin Oncol"},{"key":"2","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S1470-2045(06)70939-1","article-title":"Mechanisms of transcoelomic metastasis in ovarian cancer","volume":"7","author":"Kaye","year":"2006","journal-title":"Lancet Oncol"},{"key":"3","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0748-7983(96)80009-6","article-title":"Malignant ascites: a 2-year review from a teaching hospital","volume":"22","author":"Steele","year":"1996","journal-title":"Eur J Surg Oncol"},{"key":"4","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/annonc\/mdl499","article-title":"Pattern and prognostic factors in patients with malignant ascites: a retrospective study","volume":"18","author":"Parsons","year":"2007","journal-title":"Ann Oncol"},{"key":"5","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1593\/neo.07472","article-title":"Characterization of ovarian cancer ascites on cell invasion, proliferation, spheroid formation, and gene expression in an in vitro model of epithelial ovarian cancer","volume":"9","author":"Mes-Masson","year":"2007","journal-title":"Neoplasia"},{"key":"6","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/1476-4598-11-84","article-title":"Ovarian cancer ascites increase Mcl-1 expression in tumor cells through ERK1\/2-Elk-1 signaling to attenuate TRAIL-induced apoptosis","volume":"11","author":"Piche","year":"2012","journal-title":"Mol Cancer"},{"key":"7","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s10585-014-9658-1","article-title":"Ascites-induced shift along epithelial-mesenchymal spectrum in ovarian cancer cells: enhancement of their invasive behavior partly dependant on alphav integrins","volume":"31","author":"Kellouche","year":"2014","journal-title":"Clin Exp Metastasis"},{"key":"8","article-title":"Ascites modulates cancer cell behavior, contributing to tumor heterogeneity in ovarian cancer","author":"Song","year":"2016","journal-title":"Cancer Sci"},{"key":"9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1757-2215-3-1","article-title":"The prosurvival activity of ascites against TRAIL is associated with a shorter disease-free interval in patients with ovarian cancer","volume":"3","author":"Piche","year":"2010","journal-title":"J Ovarian Res"},{"key":"10","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/1471-2407-11-210","article-title":"Prognostic significance of IL-6 and IL-8 ascites levels in ovarian cancer patients","volume":"11","author":"Piche","year":"2011","journal-title":"BMC Cancer"},{"key":"11","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1186\/s12885-015-1511-7","article-title":"Inflammation-regulating factors in ascites as predictive biomarkers of drug resistance and progression-free survival in serous epithelial ovarian cancers","volume":"15","author":"Piche","year":"2015","journal-title":"BMC Cancer"},{"key":"12","first-page":"117","article-title":"Role of the interleukin 6 receptor family in epithelial ovarian cancer and its clinical implications","volume":"1845","author":"Ward","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1423-0127-19-23","article-title":"Isolation and characterization of stromal progenitor cells from ascites of patients with epithelial ovarian adenocarcinoma","volume":"19","author":"Shih","year":"2012","journal-title":"J Biomed Sci"},{"key":"14","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.canlet.2009.09.017","article-title":"Epithelial-mesenchymal transition in ovarian cancer","volume":"291","author":"Salzet","year":"2010","journal-title":"Cancer Lett"},{"key":"15","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nrc3447","article-title":"Regulatory networks defining EMT during cancer initiation and progression","volume":"13","author":"Berx","year":"2013","journal-title":"Nature reviews Cancer"},{"key":"16","article-title":"Ovarian cancer ascites enhance the migration of patient-derived peritoneal mesothelial cells via cMet pathway through HGF-dependent and -independent mechanisms","author":"Piche","year":"2014","journal-title":"Int J Cancer"},{"key":"17","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.4161\/cc.29951","article-title":"The bright side of ascites in ovarian cancer","volume":"13","author":"Petignat","year":"2014","journal-title":"Cell Cycle"},{"key":"18","doi-asserted-by":"crossref","first-page":"e28561","DOI":"10.1371\/journal.pone.0028561","article-title":"Copy number variation analysis of matched ovarian primary tumors and peritoneal metastasis","volume":"6","author":"Rafii","year":"2011","journal-title":"PloS one"},{"key":"19","first-page":"e28086","article-title":"The involvement of JAK-STAT3 in cell motility, invasion, and metastasis","volume":"3","author":"Cowell","year":"2014","journal-title":"JAKSTAT"},{"key":"20","first-page":"256","article-title":"Getting to know ovarian cancer ascites: opportunities for targeted therapy-based translational research","volume":"3","author":"Stenvers","year":"2013","journal-title":"Front Oncol"},{"key":"21","first-page":"566","article-title":"Profiling of cytokines in human epithelial ovarian cancer ascites","volume":"2","author":"Piche","year":"2012","journal-title":"Am J Cancer Res"},{"key":"22","first-page":"2875","article-title":"Ovarian cancer-associated ascites demonstrates altered immune environment: implications for antitumor immunity","volume":"29","author":"Oelke","year":"2009","journal-title":"Anticancer Res"},{"key":"23","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1016\/j.ejca.2011.03.026","article-title":"Cytokine analysis as a tool to understand tumour-host interaction in ovarian cancer","volume":"47","author":"Massuger","year":"2011","journal-title":"Eur J Cancer"},{"key":"24","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1126\/science.8272872","article-title":"Association of transcription factor APRF and protein kinase Jak1 with the interleukin-6 signal transducer gp130","volume":"263","author":"Taga","year":"1994","journal-title":"Science"},{"key":"25","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1126\/science.8140422","article-title":"Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6","volume":"264","author":"Darnell","year":"1994","journal-title":"Science"},{"key":"26","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/ijc.22840","article-title":"Malignant ascites protect against TRAIL-induced apoptosis by activating the PI3K\/Akt pathway in human ovarian carcinoma cells","volume":"121","author":"Piche","year":"2007","journal-title":"Int J Cancer"},{"key":"27","doi-asserted-by":"crossref","first-page":"3519","DOI":"10.1038\/onc.2010.107","article-title":"Ovarian cancer ascites protects from TRAIL-induced cell death through alphavbeta5 integrin-mediated focal adhesion kinase and Akt activation","volume":"29","author":"Piche","year":"2010","journal-title":"Oncogene"},{"key":"28","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/sj.cgt.7700899","article-title":"Inhibition of ovarian cancer metastasis by adeno-associated virus-mediated gene transfer of nm23H1 in an orthotopic implantation model","volume":"13","author":"Ma","year":"2006","journal-title":"Cancer Gene Ther"},{"key":"29","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/ijc.11676","article-title":"Expression profile of genes associated with antimetastatic gene: nm23-mediated metastasis inhibition in breast carcinoma cells","volume":"109","author":"Achary","year":"2004","journal-title":"Int J Cancer"},{"key":"30","doi-asserted-by":"crossref","first-page":"e0118080","DOI":"10.1371\/journal.pone.0118080","article-title":"Interleukin 6 receptor is an independent prognostic factor and a potential therapeutic target of ovarian cancer","volume":"10","author":"Toda","year":"2015","journal-title":"PloS one"},{"key":"31","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/sj.bjc.6604794","article-title":"Cross talk of signals between EGFR and IL-6R through JAK2\/STAT3 mediate epithelial-mesenchymal transition in ovarian carcinomas","volume":"100","author":"Ahmed","year":"2009","journal-title":"Br J Cancer"},{"key":"32","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.ctrv.2012.04.007","article-title":"Interleukin-6 signaling pathway in targeted therapy for cancer","volume":"38","author":"Zhang","year":"2012","journal-title":"Cancer Treat Rev"},{"key":"33","doi-asserted-by":"crossref","first-page":"6083","DOI":"10.1158\/1078-0432.CCR-11-0945","article-title":"Interleukin-6 as a therapeutic target in human ovarian cancer","volume":"17","author":"Cummings","year":"2011","journal-title":"Clin Cancer Res"},{"key":"34","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.1749-6632.2009.04899.x","article-title":"Genistein inhibits cell growth by modulating various mitogen-activated protein kinases and AKT in cervical cancer cells","volume":"1171","author":"Song","year":"2009","journal-title":"Annals of the New York Academy of Sciences"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.13074","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T09:57:35Z","timestamp":1596707855000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.13074"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,4]]},"references-count":34,"journal-issue":{"issue":"50","published-print":{"date-parts":[[2016,12,13]]}},"alternative-id":["13074","27825119"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.13074","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,4]]}}}